Trial Profile
The effect of adalimumab on immune markers in lesional psoriatic skin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2020
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics; Therapeutic Use
- 16 Dec 2020 Status changed from recruiting to completed.
- 17 Jun 2011 New trial record